SBIR/STTR Research Award

Assistive ExoSkeleton & ExoTendon Platform to Enable Wearable Rehabilitation Robotics

Award identifier 2b943a684595ce6eb5fa10d0a4efc18257831a0d72ac376b1ccb824a99e5a8b5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$210,176

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
RESULTS GROUP, LLC
Proposal award date
2018-05-01
Contract end date
2019-06-30
UEI
KR49VQHNMHD1
Solicitation number
PA17-302
Topic code
600

Research abstract

Project SummaryAbstract Relatedness to MissionApplication aligns with multipleNINR SBIR goalsGTechnologies to treat chronic wounds that fail to healspecificallydiabetic ulcersBDevices that improve the acceptance and use of assistive devicesBDevices that improve delivery of care to persons who have restricted movement due toperipheralvascular diseaseto allow them to better self manageDTechnologies to assist in health promotion and prevention Medical needThis application is towards rehabilitation andampsecondary prevention of Diabetic Foot UlcerDFUDFU is more costly than the most expensive cancerit is the leading cause of lower limb amputationsand survivors of lower limb amputation have a higher mortality rate than half of the topcancersInventionThe device is focused on secondary prevention of DFU by reducing pressure on the areas of the foot at greatest risk for ulcerationWith patient inputteam has designed a novel assistive device that off loads pressure from the foot by deploying a disruptive design for rehabilitation roboticsIt integrates structural exoskeletons and exo tendons to externalize lower limb forces outside of the bodyPI holds US patents on the exoskeletons deployed as a low cost easily manufactured non powered device and a motorized robotic versionIn a peer reviewed publication of team s initial proof of concept testingthe device demonstrated clinically significant off loading of greater thanwhich is similar to the off loading achieved through surgical interventionThe device also received positive patient feedback regarding gait stabilityAimPrototype refinement and instrumentationInitial proof of concept demonstrated ability to re route force outside a patient s bodyNowteam must create instrumented prototypes with specific ability to precisely adjust thedoselevel of spring force and the bio mechanical geometry at which these forces engageAimEvaluation ofdoseimpact upon off loadinggaitbalance andampconfidenceThe prototypes will be evaluated under multipledose rangingconditions toAquantify off loading of plantar pressure in areas at highest risk of DFUBmeasure impact upon factors associated with fall risk and Cestablishdoseimpact on participantsgait confidenceRationaleThe team recently completed amonth Phase I SBIR from the ACL National Institute for DisabilityIndependent Living and Rehabilitation ResearchPeer reviewed results are show that the initial prototypes were able to off load andgtof pressure by externalizing forcesTeam has been awardedissued US patentsIf successfulthis will be the first disruptive innovation in off loading in decades and illuminates key design factors for future evaluation of robotic motor assisted off loading devices and sensor controlled devices Project Narrative Diabetic Foot Ulcer is the leading cause of foot amputationits prevalence is increasing dramatically and it is more expensive burden to the US healthcare system than lung cancerthose with foot amputation have a higher mortality rate than half of the topcancersA new class of technology is arisingthe wearable rehabilitation robotthat will provide a revolutionary improvement in wound healinghoweveruntil now these devices have been too costly and unsuitable for large scale distributionThe proposed solution introduces a novel exoskeleton which can be deployed at a very low cost without a motor and was shown in proof of concept testing to off load clinically significant pressure in areas at highest risk for ulcerationthereby providing a new and disruptive option for the prevention of Diabetic Foot Ulcer and thereby the reduction of Amputation and risk of mortality

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

11 SBIR/STTR records share this UEI (2008–2025). Reported award amounts total $5,605,057. Reported amounts are not federal obligations.

Phases: Phase I, Phase II – Direct to Phase II, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.